Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8510
-0.0656 (-7.16%)
At close: Aug 20, 2026, 4:00 PM EDT
0.8500
-0.0010 (-0.12%)
After-hours: Aug 20, 2026, 6:06 PM EDT
RANI Revenue
Rani Therapeutics Holdings had revenue of $1.71M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $4.88M, up 306.42% year-over-year. In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth.
Revenue (ttm)
$4.88M
Revenue Growth
+306.42%
P/S Ratio
24.94
Revenue / Employee
$68,690
Employees
71
Market Cap
118.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.63M | 605.00K | 58.85% |
| Dec 31, 2024 | 1.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 2.72M | 2.26M | 488.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
RANI News
- 2 days ago - Rani Therapeutics initiated with a Buy at Chardan - TheFly
- 4 days ago - Rani Therapeutics reports Q2 EPS (4c), consensus (5c) - TheFly
- 7 days ago - Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update - GlobeNewsWire
- 7 days ago - Rani Therapeutics Holdings Earnings release: Q2 2026 - Filings
- 7 days ago - Rani Therapeutics Holdings Quarterly report: Q2 2026 - Filings
- 8 days ago - Rani Therapeutics Holdings Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 10 days ago - Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire